Literature DB >> 81448

Theophylline pharmacokinetics and respiratory infections.

J A Fleetham, K Nakatsu, P W Munt.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 81448     DOI： 10.1016/s0140-6736(78)91612-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

Review 1.  Pharmacokinetic interactions between theophylline and other medication (Part II).

Authors:  R A Upton
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

2.  Effect of prednisolone on theophylline pharmacokinetics in patients with chronic airflow obstruction.

Authors:  R J Fergusson; C M Scott; P Rafferty; J Gaddie
Journal:  Thorax       Date:  1987-03       Impact factor: 9.139

3.  The effect of pneumococcal vaccine on the disposition of theophylline.

Authors:  G C Cupit; T H Self; W B Bekemeyer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

4.  Depression of theophylline elimination following BCG vaccination.

Authors:  J D Gray; K W Renton; O R Hung
Journal:  Br J Clin Pharmacol       Date:  1983-12       Impact factor: 4.335

5.  Combination of aminophylline (Phyllocontin Continus tablets) and salbutamol in the management of chronic obstructive airways disease.

Authors:  C J Clark; G Boyd
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

6.  Pharmacokinetics and pharmacodynamics of methylprednisolone when administered at 8 am versus 4 pm.

Authors:  L E Fisher; E A Ludwig; J A Wald; R R Sloan; E Middleton; W J Jusko
Journal:  Clin Pharmacol Ther       Date:  1992-06       Impact factor: 6.875

7.  Influenza vaccination and theophylline pharmacokinetics in patients with chronic obstructive lung disease.

Authors:  B M Stults; P A Hashisaki
Journal:  West J Med       Date:  1983-11

Review 8.  Inflammation is a major regulator of drug metabolizing enzymes and transporters: Consequences for the personalization of drug treatment.

Authors:  Françoise Stanke-Labesque; Elodie Gautier-Veyret; Stephanie Chhun; Romain Guilhaumou
Journal:  Pharmacol Ther       Date:  2020-07-11       Impact factor: 12.310
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.